TKI-induced pure red cell aplasia: first case report of pure red cell aplasia with both imatinib and nilotinib

Tyrosine-kinase inhibitors (TKIs) represent the only hopes for long-term survival for patients with chronic myeloid leukaemia (CML) and gastrointestinal stromal tumours. Thus, uninterrupted use of TKIs is of importance in such patients. Pure red cell aplasia (PRCA) is a rare disorder, not previously...

Descripción completa

Detalles Bibliográficos
Autores principales: Poudyal, Bishesh Sharma, Tuladhar, Sampurna, Gyawali, Bishal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070250/
https://www.ncbi.nlm.nih.gov/pubmed/27843612
http://dx.doi.org/10.1136/esmoopen-2016-000058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070250/
https://www.ncbi.nlm.nih.gov/pubmed/27843612
http://dx.doi.org/10.1136/esmoopen-2016-000058

Ejemplares similares